JAK2

JAK2

Target · Non-receptor tyrosine kinase

JAK2 Janus kinase 2 · Tyrosine-protein kinase JAK2

JAK2 (Janus kinase 2, also known as JTK10) is a non-membrane spanning tyrosine kinase that transduces cytokine and growth factor signals. It phosphorylates cytokine receptors and STAT proteins, linking receptor engagement to gene transcription. Browse Assay Genie's current range of JAK2 research reagents below, or read on for the biology behind the target.

Cytoplasm and nucleusJAK family tyrosine kinaseDrives STAT signalling
1132 aa
Protein length
~131 kDa
Molecular weight
9p24.1
Gene locus
EC 2.7.10.2
Enzyme class
Target information

What is JAK2 (janus kinase 2)?

JAK2 is a non-receptor protein tyrosine kinase with a pivotal role in signal transduction. After a ligand binds its cell surface receptor, JAK2 autophosphorylates and becomes active. It then phosphorylates specific tyrosine residues on the receptor's cytoplasmic tail, creating docking sites for STAT proteins. Once recruited, the STATs are phosphorylated by JAK2, form homodimers or heterodimers, and translocate to the nucleus to activate transcription. In erythropoiesis, erythropoietin stimulation leads to JAK2 association with the erythropoietin receptor and activation of STAT5A or STAT5B.

JAK2 acts downstream of type I receptors such as the growth hormone, prolactin, leptin, erythropoietin and thrombopoietin receptors, and of type II receptors including those for IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. It mediates essential signalling in innate and adaptive immunity and contributes to cell growth, development and differentiation. It also phosphorylates CDKN1B in cell cycle control, cooperates with TEC to activate FOS transcription, and increases KCNA3 potassium channel activity. In the nucleus, JAK2 phosphorylates histone H3 at Tyr-41, a mark that excludes CBX5 (HP1 alpha) from chromatin.

The protein belongs to the Tyr protein kinase family, JAK subfamily, and sits in the HGNC groups for SH2 domain, FERM domain and Jak family tyrosine kinases. The primary isoform has an N-terminal FERM domain needed for erythropoietin receptor association, an SH2 domain that binds STATs, a pseudokinase domain and a C-terminal kinase domain. Alternative splicing gives multiple isoforms. JAK2 is a downstream target of IL-6, and dysregulated IL-6/JAK2/STAT3 signalling is linked to myeloproliferative neoplasms. A mutation in the pseudokinase domain removes its inhibitory effect, causing constitutive activity and cytokine hypersensitivity. Mutations in the JAK2 gene are associated with inflammatory diseases and malignancies.

Cytokine signalling research

JAK2 couples cytokine and growth factor receptors to STAT activation, making it a central node for studying receptor signalling.

Haematopoiesis and erythropoiesis

JAK2 links erythropoietin receptor activation to STAT5 phosphorylation and transcription of genes that modulate erythropoiesis.

Myeloproliferative neoplasm studies

Dysregulated IL-6/JAK2/STAT3 signalling and pseudokinase domain mutations are tied to proliferation and myeloproliferative neoplasms of haematopoietic stem cells.

Immunity and inflammation

JAK2 mediates innate and adaptive immune signalling, and the pathway is a therapeutic target for excessive inflammatory responses to viral infection.

Background

JAK2 frequently asked questions

What does JAK2 do?

JAK2 is a tyrosine kinase that phosphorylates cytokine and growth factor receptors after ligand binding. This creates STAT docking sites, and JAK2 then phosphorylates the recruited STATs, which dimerise and move to the nucleus to activate gene transcription.

What other names does JAK2 go by, and does it have isoforms?

JAK2 stands for Janus kinase 2, and the UniProt entry names it tyrosine-protein kinase JAK2. JTK10 is a listed alias. Alternative splicing of the JAK2 gene produces multiple transcript variants that encode distinct isoforms, according to the NCBI Gene summary.

Is JAK2 linked to disease, and is it conserved in rodents?

Mutations in JAK2 are associated with inflammatory diseases and malignancies, including myeloproliferative neoplasms. Mouse and rat both have a Jak2 ortholog. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other JAK family kinases that work alongside JAK2 in cytokine receptor signalling.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O60674; product specifications from Assay Genie datasheets.

JAK2 Product listing